Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Franck Rouby"'
Autor:
Mickaël Martin, Marion Sassier, Marion Allouchery, Thomas Lombard, Franck Rouby, Celia Bertin, Marina Atzenhoffer, Ghada Miremont-Salame, Marie-Christine Perault-Pochat, Mathieu Puyade
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Safety of rechallenge of immune checkpoint inhibitor (ICI) after grade ≥2 immune-related adverse events (irAEs) leading to ICI discontinuation remains unclear.Methods All adverse drug reactions involving at least one ICI reported up to D
Externí odkaz:
https://doaj.org/article/f69ac786f50d4394bac7f5af90c5c291
Autor:
Jean-Baptiste Davion, Franck Rouby, Sophie Gautier, Fanny Rocher, Florence Renaud, Sandrine Combret, Bénédicte Lebrun-Vignes, Louise Gaboriau, Sandrine Morell-Dubois
Publikováno v:
Neuromuscular Disorders
Neuromuscular Disorders, Elsevier, 2020, 30 (11), pp.915-920. ⟨10.1016/j.nmd.2020.09.026⟩
Neuromuscular Disorders, Elsevier, 2020, 30 (11), pp.915-920. ⟨10.1016/j.nmd.2020.09.026⟩
TNFα inhibitors, including adalimumab, are widely used in inflammatory rheumatologic and bowel diseases. Well-known adverse effects include: opportunistic infections, immunogenicity and new inflammatory manifestations. Myositis is an inflammatory di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4859f3d97a4afcd9ead3e031c9b0a4c
https://doi.org/10.1016/j.nmd.2020.09.026
https://doi.org/10.1016/j.nmd.2020.09.026
Autor:
Jean-Philippe Ranjeva, Romain Truillet, Christine Audebert, Joëlle Micallef, Alexandra Auffret, Jill C. Richardson, Marie-Noëlle Lefebvre, Céline Vervueren, Dominique Deplanque, Laura Lanteaume, David Bartrés-Faz, Anna Chan Kwong, Arnaud Beck, Catherine Cassé-Perrot, Pierre Payoux, Amélie Ponchel, Franck Rouby, Elisabeth Jouve, Marie-Claude Costes-Salon, Olivier Blin, Claudio Babilon, Régis Bordet
Publikováno v:
Journal of Clinical Psychopharmacology. 40:222-230
Purpose/background Alzheimer disease (AD) is a public health issue because of the low number of symptomatic drugs and the difficulty to diagnose it at the prodromal stage. The need to develop new treatments and to validate sensitive tests for early d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3cd9d1c9d84429591447ec93bbb8cba
https://doi.org/10.1097/jcp.0000000000001199
https://doi.org/10.1097/jcp.0000000000001199
Autor:
Marion Allouchery, Kevin Bihan, Bénédicte Lebrun-Vignes, Franck Rouby, Marie Bastin, Pirayeh Eftekhari, Marion Sassier, Fabrizio Andreelli
Publikováno v:
Thérapie
Thérapie, 2021, 76 (6), pp.695-703. ⟨10.1016/j.therap.2021.03.004⟩
Thérapie, 2021, 76 (6), pp.695-703. ⟨10.1016/j.therap.2021.03.004⟩
Summary Introduction Immune checkpoint inhibitor-induced diabetes mellitus (ICI-DM) is an immune-related adverse drug reaction (irADR). Hyperglycemia can be linked to endogenous insulin deficiency with ketoacidosis or associated with preserved beta-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66da6045feeee7906f0cbaa312c54224
https://hal.science/hal-03623623
https://hal.science/hal-03623623
Autor:
Mickaël Martin, Hoan-My Nguyen, Clément Beuvon, Johana Bene, Pascale Palassin, Marina Atzenhoffer, Franck Rouby, Marion Sassier, Marie-Christine Pérault-Pochat, Pascal Roblot, Marion Allouchery, Mathieu Puyade
Publikováno v:
Cancers; Volume 14; Issue 20; Pages: 5030
Immune checkpoint inhibitor (ICI)-related cytopenias have been poorly described. This study aimed to further characterize ICI-related cytopenias, using the French pharmacovigilance database. All grade ≥ 2 hematological adverse drug reactions involv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8f91ebedd0abd973d74e3e4c29726ce
https://doi.org/10.3390/cancers14205030
https://doi.org/10.3390/cancers14205030
Autor:
Odile Gelpi, Laurent Simon, Stéphane Schück, Jehan-Michel Behier, Alain Dutilleul, Franck Rouby, Annick Opinel, Benoît Soubeyrand, Farid Kheloufi, Geneviève Chêne, Brigitte Autran, Soizic Courcier, Franck Gérald, Véronique Dufour, Jacques Morel, Mathieu Molimard, Géraldine Ménin, Xavier Bresse, Jean-Louis Koeck, Thomas Borel, François Faurisson, Marie-Christine Truchet, Véronique Lamarque-Garnier, Clémentine Schilte, Arnaud Gagneur, Telma Lery, Odile Launay, Claire Roger
Publikováno v:
Therapies. 74:119-129
Resume Recommandation phare du Comite d’orientation de la conference citoyenne sur la vaccination, l’obligation vaccinale etendue a 11 vaccins pour les nourrissons nes depuis le 1er janvier 2018, s’inscrit dans un ensemble de recommandations de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae192c038497ddee8f8e7f5852f1aa76
https://doi.org/10.1016/j.therap.2018.11.007
https://doi.org/10.1016/j.therap.2018.11.007
Autor:
Marion Allouchery, Ghada Miremont-Salamé, Franck Rouby, Mathieu Puyade, Celia Bertin, Thomas Lombard, Marion Sassier, Mickael Martin, Marie-Christine Perault-Pochat, Marina Atzenhoffer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2020, 8 (2), pp.e001622. ⟨10.1136/jitc-2020-001622⟩
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2020, 8 (2), pp.e001622. ⟨10.1136/jitc-2020-001622⟩
BackgroundSafety of rechallenge of immune checkpoint inhibitor (ICI) after grade ≥2 immune-related adverse events (irAEs) leading to ICI discontinuation remains unclear.MethodsAll adverse drug reactions involving at least one ICI reported up to Dec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a9b1a0692b226597980f4a8dc68a166
https://jitc.bmj.com/content/8/2/e001622.full
https://jitc.bmj.com/content/8/2/e001622.full
Autor:
Charles Dolladille, Franck Thuny, Franck Paganelli, Ugo Scemama, Ariel Cohen, Franck Rouby, Joachim Alexandre, Stéphane Ederhy, Joe-Elie Salem, Jennifer Cautela
Publikováno v:
Canadian Journal of Cardiology
Canadian Journal of Cardiology, Elsevier, 2020, 36 (4), pp.476-481. ⟨10.1016/j.cjca.2019.11.035⟩
Canadian Journal of Cardiology, 2020, 36 (4), pp.476-481. ⟨10.1016/j.cjca.2019.11.035⟩
Canadian Journal of Cardiology, Elsevier, 2020, 36 (4), pp.476-481. ⟨10.1016/j.cjca.2019.11.035⟩
Canadian Journal of Cardiology, 2020, 36 (4), pp.476-481. ⟨10.1016/j.cjca.2019.11.035⟩
International audience; Isolated cases of acute coronary syndrome (ACS) associated with immune checkpoint inhibitors (ICIs) have been described without the establishment of a formal cause-and-effect relationship between treatment and adverse event. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1728ce4bee4b44ba2f4d7038c9fce99
https://hal.sorbonne-universite.fr/hal-02948357
https://hal.sorbonne-universite.fr/hal-02948357
Autor:
Nadine Petitpain, Julie Garon-Czmil, Franck Rouby, Marion Sassier, Georges Weryha, Marc Klein, Pierre Gillet, Samy Babai, Melissa Yelehe-Okouma
Publikováno v:
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2018, 12 (3), pp.e1757-e1766. ⟨10.1111/fcp.12423⟩
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2018, 12 (3), pp.e1757-e1766. ⟨10.1111/fcp.12423⟩
Fundamental & Clinical Pharmacology, 2018, 12 (3), pp.e1757-e1766. ⟨10.1111/fcp.12423⟩
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2018, 12 (3), pp.e1757-e1766. ⟨10.1111/fcp.12423⟩
Immunotherapy with immune checkpoint inhibitors (ICIs) for cancer has become increasingly prescribed in recent years. Indeed, it is used to treat both solid and hematological malignancies due to their considerable potential in treating melanoma, non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131b3edab2bdd68ec9015f10d75b8f58
https://doi.org/10.1111/fcp.12423
https://doi.org/10.1111/fcp.12423
Autor:
Marie Christine Pérault-Pochat, Sylvie Favrelière, Paul Delaunay, Franck Rouby, Martine Atzenhoffer, Claire Lafay-Chebassier, Jean-Pascal Lebreton
Publikováno v:
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2020, ⟨10.1111/fcp.12533⟩
Fundamental and Clinical Pharmacology, Wiley, 2020, ⟨10.1111/fcp.12533⟩
International audience; Hearing loss is defined as a decrease in the ability to perceive sounds which can occur suddenly or gradually and affects one ear or both. It is related to various etiologies, in particular drugs. The identification of all dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e0a27e5e3370bce3c9bb69b94af86ce
https://pubmed.ncbi.nlm.nih.gov/31912913
https://pubmed.ncbi.nlm.nih.gov/31912913